T Cell Engagers typically consist of two binding domains: one that targets a specific antigen on the surface of cancer cells and another that binds to CD3, a component of the T cell receptor complex on T cells. By physically linking a T cell to a cancer cell, T Cell Engagers facilitate the activation and proliferation of T cells, leading to the targeted destruction of the cancer cells.
